Company · founded 2007
CellSight Technologies (United States)
San Francisco, United States · cellsighttechnologies.com
- Citations, last 5 years
- 287
- Works, last 5 years
- 21
- h-index
- 26
- Scientists listed
- 4
- Grants since 2016
- 6
Grants received
2025–2028 · research · R44
Imaging intracerebral and systemic T cell immunity in patients with Alzheimer's disease using 18F-F-AraG
Jelena Levi · CellSight Technologies (United States) · funded by National Institutes of Health
2022–2024 · contract · N44
SBIR PHASE II - TOPIC 396 - IMAGING FOR CANCER IMMUNOTHERAPIES
Jelena Levi · CellSight Technologies (United States) · funded by National Institutes of Health
2019–2020 · contract · N43
SBIR PHASE I TOPIC 396 EVALUATION OF [18F]F-ARAG, A T CELL-SPECIFIC PET AGENT, AS AN IMAGING BIOMARKER PREDICTIVE OF RESPONSE TO IMMUNOTHERAPIES - MOONSHOT
Jelena Levi · CellSight Technologies (United States) · funded by National Institutes of Health
2018–2019 · contract · N01
SBIR Topic 376: A noninvasive PET imaging strategy for longitudinal monitoring of immune contexture in the tumor microenvironment. Moonshot.
Jelena Levi · CellSight Technologies (United States) · funded by National Institutes of Health
2017–2022 · research · R44
Monitoring immune response to immunotherapies in cancer patients with VisAcT PET tracer
Samuel Ray Goth · CellSight Technologies (United States) · funded by National Institutes of Health
2017–2019 · research · R44
Monitoring immune response to immunotherapies in cancer patients with VisAcT PET tracer
Samuel Ray Goth · CellSight Technologies (United States) · funded by National Institutes of Health